Skip to main content

Advertisement

Log in

Effects of mandibular advancement device treatment on arterial stiffness and glucose metabolism in patients with mild to moderate obstructive sleep apnea: a prospective 1 year study

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Study objectives

An independent association between obstructive sleep apnea (OSA) and cardiovascular events has been reported, suggesting that OSA may lead to cardiometabolic dysregulation. We prospectively investigated the effect of mandibular advancement device (MAD) treatment on arterial stiffness, glucose metabolism, and certain inflammatory markers as predictors of cardiometabolic risk in mild to moderate OSA patients.

Methods

A total of 18 patients with mild to moderate OSA were prospectively enrolled in the study to determine the effects of MAD treatment at 3 months and 1 year following initiation of the treatment. Sleep studies, arterial stiffness assessment, and laboratory analyses were obtained at the baseline and at the time of follow-up. The data collected at 1 year were compared to baseline values.

Results

There was a significant decrease in apnea-hypopnea index (AHI) after 1 year of treatment when compared to baseline (22.9 ± 5.9 to 9.7 ± 4.5, P < 0.001). Furthermore, MAD treatment was associated with reduced levels of fasting plasma glucose values after 1 year of treatment (5.3 ± 0.5 to 4.9 ± 0.5 mmol/L, P < 0.001), as well as fasting plasma insulin values (14.1 ± 7.8 to 10.9 ± 6.4 μU/mL, P < 0.05) and HOMA-IR (3.3 ± 1.8 to 2.4 ± 1.4, P < 0.001). There was significant improvement in pulse wave velocity (9.3 ± 1.9 m/s at baseline to 8.1 ± 1.7 m/s, P < 0.05) after 1 year of treatment. Plasma level of an inflammatory marker fibrinogen decreased significantly from 3.4 ± 0.7 at baseline to 3.0 ± 0.9, (P < 0.05) at 1-year follow-up.

Conclusions

The MAD treatment improved arterial stiffness, glucose metabolism, and insulin resistance in mild to moderate OSA patients after 1 year of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. The Report of an American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689

    Google Scholar 

  2. Fischer J, Dogas Z, Bassetti CL et al (2012) Standard procedures for adults in accredited sleep medicine centres in Europe. J Sleep Res 21:357–368

    Article  PubMed  Google Scholar 

  3. Roure N, Gomez S, Mediano O et al (2008) Daytime sleepiness and polysomnography in obstructive sleep apnea patients. Sleep Med 9:727–731

    Article  PubMed  Google Scholar 

  4. Phillips CL, Grunstein RR, Darendeliler MA et al (2013) Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea. Am J Respir Crit Care Med 187:879–887

    Article  PubMed  Google Scholar 

  5. Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G (2013) Obstructive sleep apnea: a cardiovascular risk in obesity and metabolic syndrome. J Am Coll Cardiol 62:569–576

    Article  PubMed  PubMed Central  Google Scholar 

  6. Stamatakis K, Sanders MH, Caffo B et al (2008) Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 31:1018–1024

    PubMed  PubMed Central  Google Scholar 

  7. Pedrosa RP, Barros IML, Drager LF et al (2014) Obstructive sleep apnea is common and independently associated with hypertension and increased arterial stiffness in consecutive perimenopausal women. Chest 146:66–72

    Article  PubMed  Google Scholar 

  8. Punjabi NM, Caffo BS, Goodwin JL et al (2009) Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. doi:10.1371/e1000132

    PubMed  PubMed Central  Google Scholar 

  9. Kent BD, Grote L, Ryan S et al (2014) Diabetes mellitus prevalence and control in sleep disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest. doi:10.1378/13-2403

    PubMed  Google Scholar 

  10. Nizankowska-Jedrzejczyk A, Almeida FR, Lowe AA et al (2014) Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial. J Clin Sleep Med 10:255–262

    PubMed  PubMed Central  Google Scholar 

  11. Buchner NJ, Quack I, Stegbauer J, Woznowski M, Kaufmann A, Rump LC (2012) Treatment of obstructive sleep apnea reduces arterial stiffness. Sleep Breath 16:123–133

    Article  PubMed  Google Scholar 

  12. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64:631–636

    CAS  PubMed  Google Scholar 

  13. Saito T, Sugiyama S, Asai K, Yasutake M, Mizuno K (2010) Effects of long-term treatment of obstructive sleep apnea on pulse wave velocity. Hypertens Res 33:844–849

    Article  PubMed  Google Scholar 

  14. Anandam A, Patil M, Akinnusi M, Jaoude P, El-Solh AA (2013) Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: an observational study. Respirology 18:1184–1190

    Article  PubMed  Google Scholar 

  15. Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G (2007) The effects of 1-year treatment with a Herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 131:740–749

    Article  PubMed  Google Scholar 

  16. Trzepizur W, Gagnadoux F, Abraham P et al (2009) Microvascular endothelial function in obstructive sleep apnea: impact of continuous positive airway pressure and mandibular advancement. Sleep Med 10:746–752

    Article  PubMed  Google Scholar 

  17. Vlachantoni IT, Dikaiakou E, Antonopoulos CN, Stefanadis C, Daskalopoulou SS, Petridou ET (2013) Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev 17:19–28

    Article  PubMed  Google Scholar 

  18. Phillips CL, Butlin M, Wong KK, Avolio AP (2013) Is obstructive sleep apnoea causally related to arterial stiffness? A critical review of the experimental evidence. Sleep Med Rev 17:7–18

    Article  PubMed  Google Scholar 

  19. Butlin M, Qasem A, Battista F et al (2013) Carotid-femoral pulse wave velocity assessment using novel cuff-based techniques. Comparison with tonometric measurement. J Hypertens 31:2237–2243

    Article  CAS  PubMed  Google Scholar 

  20. Gunjaca G, Jeroncic A, Budimir D et al (2012) A complex pattern of agreement between oscillometric and tonometric measurement of arterial stiffness in a population-based sample. J Hypertens 30:1444–1452

    Article  CAS  PubMed  Google Scholar 

  21. Kushida CA, Littner MR, Morgenthaler T et al (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28:449–521

    Google Scholar 

  22. Almeida FR, Lowe AA (2009) Principles of oral appliance therapy for the management of snoring and sleep disordered breathing. Oral Maxillofac Sur Clin North Am 21:413–420

    Article  Google Scholar 

  23. Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W (2006) Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 29:244–262

    PubMed  Google Scholar 

  24. Sutherland K, Vanderveken OM, Tsuda H et al (2014) Oral appliance treatment for obstructive sleep apnea: an update. J Clin Sleep Med 10:215–227

    PubMed  PubMed Central  Google Scholar 

  25. Phillips C, Yee B, Yang Q et al (2008) Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP. Chest 134:94–100

    Article  PubMed  Google Scholar 

  26. Pecotic R, Dodig IP, Valic M, Ivkovic N, Dogas Z (2012) The evaluation of the Croatian version of the Epworth sleepiness scale and STOP questionnaire as screening tools for obstructive sleep apnea syndrome. Sleep Breath 16:793–802

    Article  PubMed  Google Scholar 

  27. Bonora E, Formentini G, Calcaterra F et al (2002) HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25:1135–1141

    Article  PubMed  Google Scholar 

  28. Tsuiki S, Kobayashi M, Namba K et al (2010) Optimal positive airway pressure predicts oral appliance response to sleep apnoea. Eur Respir J 35:1098–1105

    Article  CAS  PubMed  Google Scholar 

  29. Dieltjens M, Vanderveken OM, Hamans E et al (2013) Treatment of obstructive sleep apnea using a custom-made titratable duobloc oral appliance: a prospective clinical study. Sleep Breath 17:565–572

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Vanderveken OM, Dieltjens M, Wouters K, De Backer W, Van de Heyning PH, Braem MJ (2013) Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing. Thorax 68:91–96

    Article  PubMed  PubMed Central  Google Scholar 

  31. Almeida FR, Henrich N, Marra C et al (2013) Patients preferences and experiences of CPAP and oral appliances for the treatment of obstructive sleep apnea: a qualitative analysis. Sleep Breath 17:659–666

    Article  PubMed  Google Scholar 

  32. Holley AB, Lettieri CJ, Shah AA (2011) Efficacy of an adjustable oral appliance and comparison with continuous positive airway pressure for the treatment of obstructive sleep apnea syndrome. Chest 140:1511–1516

    Article  PubMed  Google Scholar 

  33. Lettieri JC, Paolino N, Eliasson AH, Shah AA, Holley AB (2011) Comparison of adjustable and fixed oral appliances for the treatment of obstructive sleep apnea. J Clin Sleep Med 7:439–445

    PubMed  PubMed Central  Google Scholar 

  34. Chin K, Ohi M, Kita H et al (1996) Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 153:1972–1976

    Article  CAS  PubMed  Google Scholar 

  35. Iguchi A, Yamakage H, Tochiya M et al (2013) Effects of weight reduction therapy on obstructive sleep apnea syndrome and arterial stiffness in patients with obesity and metabolic syndrome. J Atheroscler Thromb 20:807–820

    Article  PubMed  Google Scholar 

  36. Tahrani A, Asad A, Stevens MJ (2013) Obstructive sleep apnea and diabetes: an update. Curr Opin Pulm Med 19:631–638

    Article  CAS  PubMed  Google Scholar 

  37. Fischer D, Pillar G, Malhotra A, Peled N, Lavie P (2002) Long-term follow-up of untreated patients with sleep apnoea syndrome. Respir Med 96:337–343

    Article  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Ivan Galic, DMD and Mijo Mario Vuletic, CDT for their assistance during dental examinations of patients and fabricating oral appliances. This work has been supported by the Croatian Ministry of Science, Education and Sport Grant #216-2163166-0513.

Conflict of interest

The authors declare they have no financial or material conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zoran Dogas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galic, T., Bozic, J., Ivkovic, N. et al. Effects of mandibular advancement device treatment on arterial stiffness and glucose metabolism in patients with mild to moderate obstructive sleep apnea: a prospective 1 year study. Sleep Breath 20, 69–77 (2016). https://doi.org/10.1007/s11325-015-1186-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-015-1186-y

Keywords

Navigation